ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)

Technical Analysis Report for NASDAQ stock NTLA Intellia Therapeutics. Dated: 26 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics

Intellia Therapeutics Opened at 9.57 and Closed at: 9.44, which is -1.59% of previous session's close. It moved within a range of 9.16 and 9.57
The session was a Bearish session with an average volume of 1839800, which is 21.15% of previous session's volumes.

  • Even though the stock has fallen, but its short term trend is positive and in an uptrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.

Support for tomorrow is 9.1 and resistance for tomorrow is 9.51
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 9.21, 8.98 resistance for tomorrow's hourly charts is 9.62, 9.8

10 Day SMA for Intellia Therapeutics (NTLA) is 9.24 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Intellia Therapeutics (NTLA) is 9.2 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Intellia Therapeutics (NTLA) is 12.11 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 13.43 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Intellia Therapeutics is 11.28 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Intellia Therapeutics is at 9.2 and 200 DMA is at 11.28, while 50 DMA and 100 DMA are at 12.11 and 13.43 respectively

Intellia Therapeutics (NTLA) moving average of 20 SMA is at 9.2 and 20 EMA is at 9.48

Intellia Therapeutics (NTLA) moving average of 50 SMA is at 12.11 and 50 EMA is at 11.12

Intellia Therapeutics (NTLA) moving average of 100 SMA is at 13.43 and 100 EMA is at 12.16

Intellia Therapeutics (NTLA) moving average of 200 SMA is at 11.28 and 200 EMA is at 12.83

Vanda Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Vanda Pharmaceuticals, about 26.33% more returns!

Tandem Diabetes has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Tandem Diabetes, about 1.37% more returns!

Intellia Therapeutics has performed better than Tg Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Theravance Biopharma in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Phio Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!

Petmed Express has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Petmed Express, about 93.28% more returns!

Intellia Therapeutics has performed better than Madrigal Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Altimmune Inc in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Co Diagnostics in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Corbus Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Evolus Inc in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Fulgent Genetics in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Icu Medical in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Kala Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics Technical analysis of indicators

Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Intellia Therapeutics in short term but SELL signal is weak.

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Intellia Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 9.17 and Intellia Therapeutics NTLA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.

Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And NTLA Experts View which covers a lot of information including buying and selling signals

NTLA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here

Chart Intellia Therapeutics (NTLA)  Technical (Analysis) Reports Intellia Therapeutics [

Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Intellia Therapeutics (NTLA)  Technical (Analysis) Reports Intellia Therapeutics [

 

Back to top